WHO ICTRP trial
Liposomal bupIvacaine paraverteBral blockadE Versus Ropivacane on postoperative…
ChiCTR2500100807 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500100807 |
|---|---|
| Public title | Liposomal bupIvacaine paraverteBral blockadE Versus Ropivacane on postoperative acute and chronic pain after Thoracic surgerY: A randomized, prospective controlled trial |
| Scientific title | Liposomal bupIvacaine paraverteBral blockadE Versus Ropivacane on postoperative acute and chronic pain after Thoracic surgerY: A randomized, prospective controlled trial |
| Primary sponsor | Shanghai Chest Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Interventions | Liposomal bupIvacaine paravertebral blockade group:After the induction of general anaesthesia, preoperative paravertebral nerve block was performed under the lateral position of the patient, and the drug was 15-20 ml of 0.5% ropivacaine… |
| Registration date | Apr 15, 2025 |
| Target size | Liposomal bupIvacaine paravertebral blockade group:200; Ropivacane paravertebral… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: